oplossing
Sponsors
Amsterdam UMC, Fondazione Santa Lucia IRCCS, UZ Leuven, St. Olavs Hospital HF
Conditions
Autism Spectrum Disorder (ASD)Autism spectrum disorder (ASD)Benzodiazepine dependence (F13.2)Chronic mucopurulent discharge and/or discomfort of the ocular prosthesis socketHealthy childrenMacular holeMacular puckerPsychological distress complaints
Phase 1
Phase 2
Leveraging the neural mechanisms of social reward for drug relapse prevention
Not yet recruitingCTIS2023-504518-31-00
Target: 70Updated: 2023-07-12
Effects of intranasal oxytocin in the treatment of benzodiazepine withdrawal: A pilot randomized parallel group placebo-controlled trial
Not yet recruitingCTIS2024-516262-11-00
Target: 60Updated: 2025-02-27
Exploring the mechanistic link between the oxytocinergic system and mindfulness training
RecruitingCTIS2024-513482-39-00
Start: 2025-05-15Target: 120Updated: 2025-03-18
Phase 3
Enhancing social attunement in autism via interpersonal sensorimotor synchronization therapy combined with single-dose intranasal oxytocin administration
WithdrawnCTIS2023-505253-41-00
Target: 140Updated: 2023-09-25
Enhancing social attunement in autism via interpersonal sensorimotor synchronization therapy combined with single-dose intranasal oxytocin administration
RecruitingCTIS2023-505253-41-01
Start: 2024-06-18Target: 140Updated: 2025-12-03
Evaluation of oxytocin treatment in children with autism and intellectual disability’, Multiple-dose Oxytocine - ASD and Intellectual Disability
RecruitingCTIS2024-513436-14-00
Start: 2023-05-30Target: 80Updated: 2025-04-04
Assessing Oxytocin's Role in Mitigating Psychosocial Stress in Breast Cancer Survivors
Not yet recruitingCTIS2024-519383-40-00
Target: 60Updated: 2025-08-19
Phase 4
Treating socket discharge and discomfort: randomized test of vitamin A ointment, low-dose steroids and artificial tears
WithdrawnCTIS2023-504451-27-00
Target: 100Updated: 2023-06-15
Treating socket discharge and discomfort: randomized test of vitamin A ointment, low-dose steroids and artificial tears
CompletedCTIS2023-504451-27-01
Start: 2024-02-29End: 2024-09-14Target: 40Updated: 2023-10-18
Short-term changes in cardiovascular risk determinants after temporarily stopping gender-affirming hormone therapy in older transgender women - a pilot study
CompletedCTIS2023-505143-39-00
Start: 2024-02-23End: 2025-09-29Target: 30Updated: 2023-09-15
Comparing postoperative recovery after vitrectomy using NSAID eyedrops versus steroid eyedrops
Not yet recruitingCTIS2024-518807-23-00
Target: 120Updated: 2025-07-08